Dr.Kumar lab

About Our Research Group

Led by Dr. Suresh Kumar, our research group at Management and Science University, Malaysia, is dedicated to advancing the frontiers of computational biology, bioinformatics, and AI-driven solutions in health sciences. With over 15 years of international experience, we focus on interdisciplinary research in genomics, proteomics, antimicrobial resistance, and drug/vaccine design. Our mission is to address global health challenges through innovative computational approaches, fostering collaboration, and mentoring the next generation of scientists.

Our group has a strong track record of securing research funding, publishing high-impact research (over 60 peer-reviewed articles, h-index: 18, 1800+ citations), and contributing to curriculum development in bioinformatics and data science.

About Me

I am a Associate Professor at at Management and Science University, Malaysia, with over 15 years of international academic and research experience across Malaysia, the USA, Austria, France, and the UK. I hold a Ph.D. in Natural Sciences from the University of Vienna, and an M.Sc. in Bioinformatics from Bharathiar University, India.

My academic journey includes positions at:

• Texas State University (USA)
  
  

• University of Leicester (UK)
  
  

• INIBAP, France
  
  

• INBIOSIS, National University of Malaysia
  
  

Achievements

• Listed in Stanford University’s World’s Top 2% Scientists (2024)
  
  

• Ranked #1 at MSU in Natural Sciences and Molecular Biology (AD Scientific Index 2025)
  
  

• 60+ peer-reviewed publications, h-index: 18, 1800+ citations
  
  

• PI for multiple funded research projects (FRGS & MSU seed grants)
  
  

• Supervised 4 Ph.D., 5 MSc (by research), and 100+ BSc research students
  
  

• Associate Editor, Frontiers in Cellular and Infection Microbiology (2024)
  
  

• Invited speaker at numerous international conferences and workshops

.

Research Interests

• Genomics and Transcriptomics

• AI in Healthcare and Diagnostic Prediction

• Antibiotic Resistance and Drug Target Discovery

• Long COVID Biomarker Identification

• Host-Pathogen Interaction Modelling

• Multi-Omics and Systems Biology